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Abstract In a pilot phase of a sur-
vey of the prevalence of primary
headache disorders in the Republic
of Georgia, we validated a
Georgian language questionnaire
for migraine (MIG), tension-type
headache (TTH), MIG+TTH and
trigeminal autonomic cephalalgias
(TAC). A population-based sample
of 186 people with headache com-
pleted the questionnaire and were
blindly examined by one of two
headache experts. The question-
naire diagnoses were: MIG 49,
TTH 76, MIG+TTH 45 and TAC
16. The physicians’ diagnoses
were: MIG 59, TTH 77,
MIG+TTH 34, TAC 2 and “symp-
tomatic headache” in 14 subjects.
Sensitivity and specificity for MIG
were 0.75 and 0.96, for TTH 0.79
and 0.86, and for MIG+TTH 0.61
and 0.84 respectively. Of 16 TAC
diagnoses, the physicians con-
firmed cluster headache in two
patients only. The questionnaire
can be utilised to investigate the
prevalence of MIG and of TTH. It
offers preliminary screening only
for TAC, which should be con-
firmed during a face to face exami-
nation.
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Introduction
We present the validation of a headache questionnaire in
Georgian language which has been constructed for utilisa-
tion in an epidemiological survey of the prevalences of pri-
mary headache disorders in the Republic of Georgia.
Recently, the Global Campaign to Reduce the Burden
of Headache Worldwide [1] and the Russian Linguistic
Subcommittee of the International Headache Society initi-
ated several epidemiological studies of primary headache
disorders in the countries of the former Soviet Union. The
aim of these studies is to close the gap in the knowledge of
the burden of headache in these countries.
The methodology of the epidemiological survey in
Georgia has been established previously [2]. Briefly, we first
translated and adapted the diagnostic headache questionnaire
of the German Headache Consortium [3] and presented it to
several patients. Next, medical residents performed a door-
to-door survey presenting the questionnaire to 153 members
of consecutive households. All subjects reporting headache
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were subsequently invited for a neurological examination.
We found fairly good values for sensitivity and specificity of
the questionnaire and obtained plausible estimates of the
prevalences of migraine (MIG), tension-type headache
(TTH) and chronic headache.
Here we validate the questionnaire by estimating the pre-
cision of headache diagnoses made by this instrument in a
larger population-based sample of people with headache.
Methods
The study protocol was approved by the Georgian National
Council on Bioethics.
Construction of questionnaire
We adapted a questionnaire that had been used and validated for
epidemiological headache research in Germany [3]. It was trans-
lated from German into the Georgian language by ZK and coun-
terchecked by AD. Both of them are fluent in Georgian and
German languages. It had four parts: (a) personal data; (b) a med-
ical enquiry, including questions related to MIG not considering
symptoms of migraine aura, TTH, trigeminal autonomic cephalal-
gias (TAC) and the use of acute and preventative headache med-
ication as well as any other medications; (c) socio-demographic
status; and (d) enquiry into willingness to pay (WTP) for acute
and preventative headache medication.
The medical enquiry began with a screening question: “Have
you had headache last year not related to flu, hangover, cold or
head injury?” as recommended by earlier studies [4]. Subjects
who responded “yes” to this question were asked to complete the
questionnaire. Subjects who responded “no” were asked to
respond to the demographic and general medical questions only.
Questions relating to MIG, TTH and TAC were based on the
International Classification of Headache Disorders, 2
nd edition
(ICHD-2) [5]. From the German experience we expected to
achieve high sensitivity and specificity for MIG and TTH but to
be able only to screen for possible cluster headache [6].
Subjects
The first phase of the epidemiological survey was conducted in
two districts of Tbilisi, the Capital of Georgia, occupied by multi-
storey apartment buildings with 40–100 households per building.
From the survey sample of 700 people, representative of the
demographic structure of the entire city population of approxi-
mately 1.5 million inhabitants, we drew a random sub-sample of
200 subjects from those who had answered “yes” to the screening
question. Three to six months after the questionnaire study the
subjects were invited for a free neurological examination, which
was performed by one of two headache experienced neurologists
(MK or AD), both ignorant of the questionnaire diagnoses.
Statistics
Sensitivity, specificity and positive and negative predictive values
were calculated for MIG, TTH and MIG+TTH using physicians’
diagnoses as the gold standard. Cohen’s kappa with 95% confi-
dence interval (CI) was calculated for the overall agreement
between physician and questionnaire diagnoses. Data analysis
was performed by SPSS 13.0.
Results
Of the 200 subjects invited to participate, 14 (7%) refused;
therefore, the validity of the questionnaire was assessed in
186 subjects. Of these, 132 (71%) were female. Mean age
was 45.5±12.4 years.
Table 1 Age and gender distribution among the diagnostic groups
1A Distribution of headache disorders according to the questionnaire
Total (N=186) MIG (N=49) TTH (N=76) TAC (N=16) MIG+TTH (N=45)
Years: mean (SD) 45.5 (12.4) 38.5 (10.5) 44.8 (13.1) 34.7 (10.1) 40.4 (13.5)
Gender: m/w 33/153 10/39 13/63 4/12 7/38
1B Distribution of headache disorders according to physicians
Total MIG  TTH  TAC  MIG+TTH  Symptomatic 
(N=186) (N=59) (N=77) (N=2) (N=34) headaches* (N=14)
Years: mean (SD) 45.4 (12.4) 36.3 (10.3) 42.9(12.8) 39; 59 42.8 (12.7)
Gender: m/w 33/153 9/50 15/62 2/0 7/27
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Validity of all questionnaire diagnoses
The questionnaire diagnosed MIG in 49 subjects, TTH in 76
subjects, MIG+TTH in 45 subjects and TAC in 16 subjects.
The physicians diagnosed MIG in 59 cases, TTH in 77 cases,
MIG+TTH in 34 subjects and cluster headache in two sub-
jects. The physicians uncovered symptomatic headaches in
14 subjects (7.5%): seven had headache mainly associated
with hypertensive crises, which was resolved following the
anti-hypertensive treatment, two had post-traumatic
headache, one had a brain tumour and four had frontal sinusi-
tis. Tables 1A and 1B show the demographic characteristics
and distribution of headache syndromes. Table 2 demon-
strates the agreements between questionnaire- and physician-
diagnoses. Of the 16 subjects diagnosed with TAC by ques-
tionnaire, the physicians confirmed only two. Others were
MIG with cluster-like autonomic symptoms. Table 3 sum-
marises the sensitivity, specificity and positive and negative
predictive values as well as the corresponding confidence
intervals for each diagnosis. The overall Cohen’s Kappa
coefficient was 0.60 (95%CI: 0.50–0.71).
Discussion
We validated a questionnaire for MIG, TTH and TAC in a
population-derived sample of 186 people with headache.
We found that values for sensitivity, specificity and positive
and negative prediction were fairly high for MIG and for
TTH but lower for the combination of MIG and TTH. The
overall agreement between the questionnaire- and physi-
cian-diagnoses was 0.60, which should be considered as a
“strong” agreement level [7].
On this evaluation, the quality of the questionnaire is
comparable with that of the original German-language ver-
sion [3]. It is also in line with the qualities of others report-
ed in the international literature [8-15]. Sensitivity and
specificity are usually higher when an instrument focuses
on MIG only. Lipton et al. presented a very short screening
questionnaire for MIG, with only three items, and achieved
a sensitivity of 0.81 and a specificity of 0.75, with a kappa
coefficient of 0.68 [11]. More detailed migraine-specific
questionnaires have been presented: the instrument of
Kallela et al. obtained a sensitivity of 0.99 and a specifici-
ty of 0.96 [16]. Questionnaires for the diagnosis of TTH are
rare. Rasmussen presented a questionnaire with a sensitivi-
ty of 43% and specificity of 96% [7]. Questionnaires seek-
ing more than one diagnosis have achieved considerably
lower agreement levels. Hagen et al. differentiated between
migraine, non-migraine headache and chronic headache
with Kappa coefficients of 0.59, 0.43 and 0.44 respectively
[17]. The questionnaire evaluated by Rasmussen et al. cov-
ered migraine and episodic and chronic TTH, with relative-
ly low Kappa coefficients of 0.43, 0.30 and 0.24 respective-
ly [7].
Our results demonstrate that the questionnaire can be
used in population-based epidemiological studies to assess
Table 2 Agreement between physician- and questionnaire-diagnoses for the entire study population
Physician
MIG TTH TAC MIG+TTH Symptomatic Total
headache
Questionnaire MIG 44 1 0 4 0 49
TTH 3 61 0 6 6 76
TAC 5 5 2 3 1 16
MIG+TTH 7 10 0 21 7 45
Total 59 77 2 34 14 186
Table 3 Sensitivity, specificity and positive and negative predictive values for each of the diagnoses migraine, tension-type headache and
migraine plus tension-type headache
Sensitivity (95% CI) Specificity (95% CI) PPV (95% CI) NPV (95% CI)
Migraine 0.75 (0.64–0.86) 0.96 (0.92–0.99) 0.89 (0.81–0.98) 0.89 (0.84–0.94)
Tension-type headache 0.79 (0.70–0.88) 0.86 (0.80–0.93) 0.8 (0.71–0.89) 0.85 (0.79–0.92)
Migraine plus tension-type headache 0.62 (0.45–0.78) 0.84 (0.78–0.90) 0.47 (0.32–0.61) 0.91 (0.86–0.96)
PPV, positive predictive value; NPV, negative predictive value; CI, 95% confidence interval324
the prevalence of MIG, TTH and, less reliably, the combi-
nation of MIG and TTH. It cannot be used to diagnose
TAC. Especially MIG patients with cluster-like autonomic
symptoms, which are not rare [18] symptoms, were not cor-
rectly diagnosed. Future studies will have to show whether
it has sufficient sensitivity to be useful as a screening tool
for possible TAC cases. The German version had very high
sensitivity (100%) but quite low specificity [6], so that all
suspected cases must undergo neurological consultation.
Several limitations of the study should be mentioned. The
neurological examination was done by one of two neurolo-
gists, thus excluding the possibility of a cross-validation.
We were not able to develop questions appropriate for diag-
nosis of aura and therefore neglected this aspect completely.
All subjects selected because they reported headache
proved to have at least one headache disorder. The speci-
ficity of the screening question for headache was therefore
100%. However, we did not include screen-negative partic-
ipants in the validation study, so cannot determine the sen-
sitivity of the screening question. Previous studies indicate
that screen-negative people may have some headache, even
MIG [19, 20]. Hence, prevalence figures in the main study
will be minimum estimates.
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